|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Current receivables, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| All other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment (net of accumulated depreciation of $6,983 and $6,686, respectively) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Contract and other deferred assets | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| All other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Progress collections and deferred income | ||||||||||||||||||||
| All other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Liabilities for pensions and other postretirement benefits | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| All other liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Class A Common Stock, $0.0001 par value - 2,000 authorized, 992 and 987 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained loss | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Baker Hughes Company equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock issued (in shares) | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Common stock outstanding (in shares) | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock |
Loading...
